SCHEMBL29770002

SCHEMBL29770002

COc1ccc2c(c1)nnn2-c1cccc(CCNS(N)(=O)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 5/20 0.49
▸ CA2 P00918 5/20 0.49
▸ CA14 Q9ULX7 5/20 0.49
▸ CA9 Q16790 4/20 0.49
▸ CA12 O43570 4/20 0.49
▸ CA5A P35218 2/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ POLB P06746 3/20 0.43
▸ ALDH1A1 P00352 6/20 0.40
▸ MAPT P10636 2/20 0.40
▸ S1PR4 O95977 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ S1PR1 P21453 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27128150 1.00 CA1 (0.49) CA1CA2CA14CA9CA12
SCHEMBL27115153 0.90 ENPP1 (0.45) CA1CA2CA9CA12SMN1; SMN2
SCHEMBL29769986 0.90 ENPP1 (0.45) CA1CA2CA9CA12SMN1; SMN2
Hydrochloric Acid SCHEMBL27116242 0.88 CA1 (0.57) CA1CA2CA14CA9CA12
SCHEMBL26907866 0.84 ALDH1A1 (0.41) SMN1; SMN2POLBALDH1A1MAPTS1PR4
Hydrochloric Acid SCHEMBL26907868 0.82 TAAR1 (0.51) SMN1; SMN2POLBALDH1A1MAPTS1PR4
Hydrochloric Acid SCHEMBL29769994 0.82 TAAR1 (0.51) SMN1; SMN2POLBALDH1A1MAPTS1PR4
SCHEMBL27120303 0.80 CA1 (0.44) CA1CA2CA9CA12SMN1; SMN2
SCHEMBL29769991 0.80 CA1 (0.44) CA1CA2CA9CA12SMN1; SMN2
Hydrochloric Acid SCHEMBL27116779 0.79 ENPP1 (0.52) CA1CA2CA14CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116882-A1 NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF TXINNO BIOSCIENCE INC. (KR) 2024-04-11 — — US claimed
WO-2022164249-A1 NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF 주식회사 티씨노바이오사이언스 2022-08-04 — — WO claimed
WO-2022164249-A1 NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF 주식회사 티씨노바이오사이언스 2022-08-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116882-A1 NOVEL BENZOTRIAZOLE DERIVATIVE HAVING INHIBITORY ACTIVITY AGAINST ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE, AND USE THEREOF ENPP1, ENPP3, TPP1 CA1 3204/4885CA2 1586/4885CA14 4696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback